Mr. Scavilla was appointed as President and Chief Executive Officer effective August 1, 2025. Previously, Mr. Scavilla served as President and Chief Executive Officer of Globus Medical, Inc. ( Globus Medical ) from April 2022 through July 18, 2025 where he led Globus acquisition of NuVasive, Inc. and integrated the two organizations to create the second largest spine technology company in the world with a greater than $12 billion market cap. Prior to that, Mr. Scavilla was Executive Vice President, Chief Commercial Officer and President, Trauma, of Globus Medical where he scaled its manufacturing and distribution capabilities and launched the Orthopedics and Trauma business unit, and prior to that he was Chief Financial Officer of Globus Medical. Prior to joining Globus Medical, Mr. Scavilla spent 28 years in increasing leadership roles within Johnson & Johnson (J&J), including serving as Chief Financial Officer, Global Vice President Finance & Business Operations of J&J Vision, and as Chief Financial Officer, Worldwide Vice President Finance of Advanced Sterilization Products J&J s infection prevention business within its MedTech business unit helping to capture the number one market position in Sterilization. Additional roles at J&J include financial management positions at McNeil Consumer Healthcare (Kenvue), Centocor Biologics, and Cilag Schaffhausen Operations in Switzerland (Janssen Pharmaceutical). Mr. Scavilla joined Dentsply Sirona Inc. s Board of Directors in February 2025 and was previously a member of the Audit and Finance Committee. He previously served on Globus Medical s Board of Directors and was a member of the Nominating and Corporate Governance Committee. Mr. Scavilla previously served on the board of directors of Impulse Dynamics, a privately held medical technology company focused on minimally invasive treatment options for heart failure patients, from November 2021 to July 2023. Mr. Scavilla received a B.S. in Finance and Organizational Behavior from LaSalle University and holds an MBA in International Management from Temple University. Director since 2025 Age: 61 Board Committees: None Other Public Company Boards: None Selected Key Qualifications and Experience: Large Company Experience as an Executive Mr. Scavilla brings extensive leadership experience from senior executive roles at large companies, consistently driving strategic growth and operational excellence. Medical Device or Industry Experience Mr. Scavilla has deep expertise in the medical device industry, with a strong track record of driving innovation, product development, and commercial success. International Business Experience Mr. Scavilla has successfully led global operations with an extensive understanding of key international markets.